[144] eXp World Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for eXp World Holdings, Inc. (EXPI) discloses a proposed Rule 144 sale of 15,000 shares of common stock via J.P. Morgan Securities LLC on 08/05/2025 (aggregate market value $151,500), against 157,232,312 shares outstanding. The shares were acquired as compensation on 01/25/2021.

Recent disposition: Randall D. Miles previously sold 10,000 common shares on 06/10/2025 for gross proceeds of $91,200.

Filer contact, date of notice, and signature fields are not populated in the provided content. The filing includes the standard Rule 144 representation regarding material nonpublic information.

Insights

Securities Analyst

TL;DR: Small insider sale disclosure; amount immaterial relative to outstanding shares and unlikely to change valuation materially.

The Form 144 reports a proposed sale of 15,000 common shares (aggregate value $151,500) via J.P. Morgan on 08/05/2025 and notes a prior sale of 10,000 shares on 06/10/2025 for $91,200. Relative to 157,232,312 shares outstanding, these transactions represent a de minimis percentage of float. The filing shows acquisition as compensation on 01/25/2021 and includes the standard attestation about lack of undisclosed material information. No dates/signature for the filer are present in the provided content.

Corporate Governance Expert

TL;DR: Routine insider reporting under Rule 144; disclosure consistency with trading requirements but not materially informative.

The notice identifies J.P. Morgan Securities LLC as the broker and documents the acquisition source as issuer compensation. The disclosure meets Rule 144 procedural requirements by specifying class, amounts, acquisition date, and planned sale date. Absent additional context (e.g., plan adoption date, filer identity details, or linked SEC filings), this remains a routine compliance disclosure rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	15000	151500	157232312	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/25/2021	Compensation	Issuer			15000	01/25/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Randall D. Miles C/o eXp World Holdings, Inc. 2219 Rimland Drive, Suite 301 Bellingham WA 98226	Common Stock	06/10/2025	10000	91200

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EXPI Form 144 disclose?

The filing discloses a proposed sale of 15,000 common shares via J.P. Morgan Securities LLC on 08/05/2025 with aggregate market value $151,500.

Who acquired the securities and when?

The 15,000 shares were acquired as compensation from the issuer on 01/25/2021.

Were there any recent insider sales disclosed?

Yes. Randall D. Miles sold 10,000 common shares on 06/10/2025 for gross proceeds of $91,200.

How many shares outstanding does the filing report?

The filing lists 157,232,312 shares outstanding.

Which broker is handling the proposed sale?

The broker named in the filing is J.P. Morgan Securities LLC, address: 390 Madison Avenue, 6th Floor, New York, NY 10017.